Design, Biochemical, Biophysical and Biological Properties of Cooperative Antisense Oligonucleotides

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 1995 Sep 11

PMID 7567472

Citations 10

Authors

E R Kandimalla

A Manning

C Lathan

R A Byrn

S Agrawal

Affiliations

Soon will be listed here.

Abstract

Short oligonucleotides that can bind to adjacent sites on target mRNA sequences are designed and evaluated for their binding affinity and biological activity. Sequence-specific binding of short tandem oligonucleotides is compared with a full-length single oligonucleotide (21mer) that binds to the same target sequence. Two short oligonucleotides that bind without a base separation between their binding sites on the target bind cooperatively, while oligonucleotides that have a one or two base separation between the binding oligonucleotides do not. The binding affinity of the tandem oligonucleotides is improved by extending the ends of the two oligonucleotides with complementary sequences. These extended sequences form a duplex stem when both oligonucleotides bind to the target, resulting in a stable ternary complex. RNase H studies reveal that the cooperative oligonucleotides bind to the target RNA with sequence specificity. A short oligonucleotide (9mer) with one or two mismatches does not bind at the intended site, while longer oligonucleotides (21mers) with one or two mismatches still bind to the same site, as does a perfectly matched 21mer, and evoke RNase H activity. HIV-1 inhibition studies reveal an increase in activity of the cooperative oligonucleotide combinations as the length of the dimerization domain increases.

Citing Articles

Multivalent DNAzyme agents for cleaving folded RNA.

Dubovichenko M, Batsa M, Bobkov G, Vlasov G, El-Deeb A, Kolpashchikov D Nucleic Acids Res. 2024; 52(10):5866-5879.

PMID: 38661191 PMC: 11162777. DOI: 10.1093/nar/gkae295.

Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3.

Aghdaei H, Jamshidi N, Chaleshi V, Jamshidi N, Sadeghi A, Zali M Gastroenterol Hepatol Bed Bench. 2021; 14(4):295-303.

PMID: 34659656 PMC: 8514217.

The Evolution of Antisense Oligonucleotide Chemistry-A Personal Journey.

Agrawal S Biomedicines. 2021; 9(5).

PMID: 34063675 PMC: 8147625. DOI: 10.3390/biomedicines9050503.

Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes.

Pires V, Simoes R, Mamchaoui K, Carvalho C, Carmo-Fonseca M PLoS One. 2017; 12(7):e0181065.

PMID: 28742140 PMC: 5524367. DOI: 10.1371/journal.pone.0181065.

Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.

Shimo T, Tachibana K, Saito K, Yoshida T, Tomita E, Waki R Nucleic Acids Res. 2014; 42(12):8174-87.

PMID: 24935206 PMC: 4081108. DOI: 10.1093/nar/gku512.

References

Maher 3rd L, Dolnick B . Specific hybridization arrest of dihydrofolate reductase mRNA in vitro using anti-sense RNA or anti-sense oligonucleotides. Arch Biochem Biophys. 1987; 253(1):214-20. DOI: 10.1016/0003-9861(87)90654-0. View

Harada S, Koyanagi Y, Yamamoto N . Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 1985; 229(4713):563-6. DOI: 10.1126/science.2992081. View

Vujcic L, Shepp D, Klutch M, Wells M, Hendry R, Wittek A . Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. J Infect Dis. 1988; 157(5):1047-50. DOI: 10.1093/infdis/157.5.1047. View

Maher 3rd L, Dolnick B . Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system. Nucleic Acids Res. 1988; 16(8):3341-58. PMC: 336498. DOI: 10.1093/nar/16.8.3341. View

Crum C, Johnson J, Nelson A, Roth D . Complementary oligodeoxynucleotide mediated inhibition of tobacco mosaic virus RNA translation in vitro. Nucleic Acids Res. 1988; 16(10):4569-81. PMC: 336649. DOI: 10.1093/nar/16.10.4569. View

Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P . Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods. 1988; 20(4):309-21. DOI: 10.1016/0166-0934(88)90134-6. View

Posner M, Hideshima T, Cannon T, Mukherjee M, Mayer K, Byrn R . An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J Immunol. 1991; 146(12):4325-32. View

Young S, Wagner R . Hybridization and dissociation rates of phosphodiester or modified oligodeoxynucleotides with RNA at near-physiological conditions. Nucleic Acids Res. 1991; 19(9):2463-70. PMC: 329458. DOI: 10.1093/nar/19.9.2463. View

Herschlag D . Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better. Proc Natl Acad Sci U S A. 1991; 88(16):6921-5. PMC: 52205. DOI: 10.1073/pnas.88.16.6921. View

10.

Woolf T, Melton D, Jennings C . Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci U S A. 1992; 89(16):7305-9. PMC: 49698. DOI: 10.1073/pnas.89.16.7305. View

11.

Baudin F, Marquet R, Isel C, Darlix J, Ehresmann B, Ehresmann C . Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol. 1993; 229(2):382-97. DOI: 10.1006/jmbi.1993.1041. View

12.

Agrawal S, Tang J . GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Antisense Res Dev. 1992; 2(4):261-6. DOI: 10.1089/ard.1992.2.261. View

13.

Sundquist W, Heaphy S . Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc Natl Acad Sci U S A. 1993; 90(8):3393-7. PMC: 46306. DOI: 10.1073/pnas.90.8.3393. View

14.

Stein C, Cheng Y . Antisense oligonucleotides as therapeutic agents--is the bullet really magical?. Science. 1993; 261(5124):1004-12. DOI: 10.1126/science.8351515. View

15.

Awang G, Sen D . Mode of dimerization of HIV-1 genomic RNA. Biochemistry. 1993; 32(42):11453-7. DOI: 10.1021/bi00093a024. View

16.

Gryaznov S, Lloyd D . Modulation of oligonucleotide duplex and triplex stability via hydrophobic interactions. Nucleic Acids Res. 1993; 21(25):5909-15. PMC: 310473. DOI: 10.1093/nar/21.25.5909. View

17.

Bayever E, Iversen P, Bishop M, Sharp J, Tewary H, Arneson M . Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev. 1993; 3(4):383-90. DOI: 10.1089/ard.1993.3.383. View

18.

Crooke S, Grillone L, Tendolkar A, Garrett A, Fratkin M, Leeds J . A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts. Clin Pharmacol Ther. 1994; 56(6 Pt 1):641-6. DOI: 10.1038/clpt.1994.189. View

19.

Padmapriya A, Tang J, Agrawal S . Large-scale synthesis, purification, and analysis of oligodeoxynucleotide phosphorothioates. Antisense Res Dev. 1994; 4(3):185-99. DOI: 10.1089/ard.1994.4.185. View

20.

Galbraith W, Hobson W, Giclas P, Schechter P, Agrawal S . Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res Dev. 1994; 4(3):201-6. DOI: 10.1089/ard.1994.4.201. View